Trials / Completed
CompletedNCT01573364
Prevalence and Reversibility of Lung Hyperinflation in Asthma
Evaluation of the Prevalence and the Reversibility of the Lung Hyperinflation in Uncontrolled Persistent Asthmatic Patients With Dyspnea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 450 (actual)
- Sponsor
- Chiesi Farmaceutici S.p.A. · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this observational study is to evaluate the pulmonary hyperinflation and its immediate reversibility to a short acting beta2 agonist test in uncontrolled persistent asthmatic patients with dyspnea.
Detailed description
The other objectives are : * the evaluation of the hyperinflation defined by an increase of the residual volume (RV), * the observation of the relationship between the hyperinflation and the asthma characteristics, * the study of the improvement of the functional parameters after a reversibility test * the evaluation of the correlation between hyperinflation parameters evolution, chest tightness and dyspnea
Conditions
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-10-01
- Completion
- 2012-01-01
- First posted
- 2012-04-09
- Last updated
- 2012-04-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01573364. Inclusion in this directory is not an endorsement.